Yixin Shi

US Patent:

20210386795, Dec 16, 2021

Filed:

Feb 20, 2020

Appl. No.:

17/433225

Inventors:

- Scottsdale AZ, US
Lingchen FU - Tempe AZ, US
Yixin SHI - Phoenix AZ, US
Bo NING - Tempe AZ, US

International Classification:

A61K 35/74
C12N 1/20
C07K 14/255
C12N 9/12
A61P 35/00

Abstract:

The present disclosure relates to genetically modified strains of engineered to be tumor navigating and to alter tumor metabolism in the tumor microenvironment. Also provided herein are methods of producing and methods of using such genetically modified strains to treat cancer.